Medimaps Group is a leading global medical software analytics company founded by a group of clinical practitioners and researchers, based in Switzerland with offices in the US and in France. It specialises in the engineering, research, development, and commercialisation of medical software applications based on patented multi-purpose technologies.
Medimaps flagship product, TBS iNsight® software, is an advanced application for DXA that evaluates the quality of the trabecular bone microarchitecture, known as TBS: Trabecular Bone Score.
See also Imaging: TBS - and look out for the FREE trial
